Please login to the form below

Not currently logged in
Email:
Password:

DVT

This page shows the latest DVT news and features for those working in and with pharma, biotech and healthcare.

AbbVie builds case for arthritis blockbuster-in-waiting upadacitinib

AbbVie builds case for arthritis blockbuster-in-waiting upadacitinib

as pulmonary embolism (PE) or deep vein thrombosis (DVT) and an uncompetitive dose.

Latest news

More from news
Approximately 9 fully matching, plus 42 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • FCB Halesway

    Eczema. BMS. Metastatic melanoma. Lung cancer. Boehringer Ingelheim. VTE prophylaxis. DVT/PE.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN Healthcare

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics